Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
28 Results for "
atherogenic
" in MedChemExpress (MCE) Product Catalog:
Products (28)
28 Results for "atherogenic" in MCE Product Catalog:
10
10 Publications Verification
Cat. No.: HY-N0292
CAS No.: 32619-42-4
Category:
Cardiovascular Disease Anti-aging Plants Canarium album (Lour.) Rauesch. Iridoids Terpenoids Burseraceae Extract Phenols Polyphenols Disease Research Fields Inflammation/Immunology Cancer
Target:
7
Category:
Target:
3
3 Cited Publications
Cat. No.: HY-19900
CAS No.: 1252679-52-9
Research Areas:
ITX5061 is an orally active type II non-competitive p38 MAPK inhibitor. ITX5061 increases HDL-C levels by inhibiting SR-BI activity. ITX5061 also moderately elevates ApoA-I levels. ITX5061 reduces early atherosclerotic lesions in the aortic arch of mice fed an atherogenic diet. ITX5061 can be used in the research of atherosclerosis .
2
2 Cited Publications
Cat. No.: HY-N4137
CAS No.: 13850-16-3
Category:
Cardiovascular Disease Triterpenes Terpenoids Rosaceae Extract Plants Disease Research Fields Rosa rugosa Thunb.
Target:
2
Research Areas:
Infection Neurological Disease Inflammation/Immunology Cancer
TMI-1 (WAY-171318) inhibits TNF converting enzyme (TACE) (IC50 of 8.4 nM), ADAM-TS-4, ADAM-17 and various MMPs with oral activity. TMI-1 significantly suppresses the secretion of TNF-α , alleviating collagen-induced arthritis in mice. TMI-1 inhibits cancer cell proliferation, induces apoptosis through a caspase-dependent pathway. TMI-1 also reverses TRPV1 upregulation and lowers the levels of inflammatory factors (TNF-α、IL-1β、IL-6) in nerve cells, protecting against paclitaxel-induced neurotoxicity. TMI-1 leads to changes in pro-atherogenic lipoprotein profiles, but does not affect the progression of early lesions .
1
Target:
Research Areas:
Obicetrapib (TA-8995; DEZ-001) is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) .
1
Category:
Natural Products Microorganisms Marine algae Marine natural products Endogenous metabolite
Target:
Cat. No.: HY-W015780
CAS No.: 150-78-7
Target:
Synonyms: IONIS ANGPT-L3Rx sodium; ISIS 703802 sodium
Target:
Research Areas:
Vupanorsen (sodium) is an N-acetyl galactosamine-conjugated antisense oligonucleotide that inhibits Angiopoietin-like 3 (ANGPTL3) protein synthesis. Vupanorsen (sodium) lowers triglycerides and atherogenic lipoproteins.
Cat. No.: HY-N0292R
CAS No.: 32619-42-4
Synonyms: PAzePC; Azelaoyl PC; 1-Palmitoyl-2-Azelaoyl PC
Target:
Research Areas:
Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species which are cytotoxic and pro-atherogenic. Many of these substances were isolated and purified from oxLDL and identified as phosphatidylcholine species containing a fragmented, oxidized short-chain fatty acid remnant at the sn-2 position. PAz-PC (Azelaoyl PC) is one of the predominant oxLDL species and may be one of the important structural determinants of oxLDL.
Cat. No.: HY-153497
CAS No.: 2097587-62-5
Synonyms: IONIS ANGPT-L3Rx; ISIS 703802
Target:
Research Areas:
Vupanorsen is an N-acetyl galactosamine-conjugated antisense oligonucleotide that inhibits Angiopoietin-like 3 (ANGPTL3) protein synthesis. Vupanorsen lowers triglycerides and atherogenic lipoproteins.
Cat. No.: HY-P10258
CAS No.: 867376-23-6
Target:
Research Areas:
Cat. No.: HY-120309
CAS No.: 136451-58-6
Target:
Research Areas:
BMY 42393 is an orally active prostacyclin agonist which suppresses monocyte-macrophage atherogenic activity and cytokine production. BMY 42393 can be used for atherosclerosis research .
Cat. No.: HY-N4137R
CAS No.: 13850-16-3
Target:
Cat. No.: HY-120943
CAS No.: 221564-97-2
Synonyms: BM 17.0744
Target:
Research Areas:
K-111 (BM-170744) is an oral active PPAR alpha agonist. K-111 show efficacy in improving insulin resistance, reducing body weight, and ameliorating atherogenic dyslipidemia. K-111 can be used for study of type 2 diabetes, dyslipidaemia, obesity and the metabolic syndrome .
Cat. No.: HY-P5169
CAS No.: 608513-82-2
Target:
Research Areas:
Cat. No.: HY-113342R
CAS No.: 566-28-9
Category:
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
